Your browser doesn't support javascript.
loading
Variant-specific pathophysiological mechanisms of AFF3 differently influence transcriptome profiles.
Bassani, Sissy; Chrast, Jacqueline; Ambrosini, Giovanna; Voisin, Norine; Schütz, Frédéric; Brusco, Alfredo; Sirchia, Fabio; Turban, Lydia; Schubert, Susanna; Jamra, Rami Abou; Schlump, Jan-Ulrich; DeMille, Desiree; Bayrak-Toydemir, Pinar; Nelson, Gary Rex; Wong, Kristen Nicole; Duncan, Laura; Mosera, Mackenzie; Gilissen, Christian; Vissers, Lisenka E L M; Pfundt, Rolph; Kersseboom, Rogier; Yttervik, Hilde; Hansen, Geir Åsmund Myge; Falkenberg Smeland, Marie; Butler, Kameryn M; Lyons, Michael J; Carvalho, Claudia M B; Zhang, Chaofan; Lupski, James R; Potocki, Lorraine; Flores-Gallegos, Leticia; Morales-Toquero, Rodrigo; Petit, Florence; Yalcin, Binnaz; Tuttle, Annabelle; Elloumi, Houda Zghal; Mccormick, Lane; Kukolich, Mary; Klaas, Oliver; Horvath, Judit; Scala, Marcello; Iacomino, Michele; Operto, Francesca; Zara, Federico; Writzl, Karin; Maver, Ales; Haanpää, Maria K; Pohjola, Pia; Arikka, Harri; Iseli, Christian.
Afiliação
  • Bassani S; Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland.
  • Chrast J; Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland.
  • Ambrosini G; Bioinformatics Competence Center, University of Lausanne, Lausanne, Switzerland.
  • Voisin N; Bioinformatics Competence Center, Ecole Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
  • Schütz F; Center for Integrative Genomics, University of Lausanne, Lausanne, Switzerland.
  • Brusco A; Biostatistics platform, University of Lausanne, Lausanne, Switzerland.
  • Sirchia F; Department of Neurosciences Rita Levi-Montalcini, University of Turin, 10126 Turin, Italy.
  • Turban L; Medical Genetics Unit, Città della Salute e della Scienza University Hospital, 10126 Turin, Italy.
  • Schubert S; Department of Neurosciences Rita Levi-Montalcini, University of Turin, 10126 Turin, Italy.
  • Jamra RA; Medical Genetics Unit, Città della Salute e della Scienza University Hospital, 10126 Turin, Italy.
  • Schlump JU; Institute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany.
  • DeMille D; Institute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany.
  • Bayrak-Toydemir P; Institute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany.
  • Nelson GR; Department of Pediatrics, Centre for Neuromedicine, Gemeinschaftskrankenhaus Herdecke Gerhard-Kienle-Weg, Herdecke, Germany.
  • Wong KN; Genomics Analysis 396, ARUP Laboratories, Salt Lake City, Utah, USA.
  • Duncan L; Pediatric Neurology, University of Utah School of Medicine, Salt Lake City, Utah, USA.
  • Mosera M; Pediatric Neurology, University of Utah School of Medicine, Salt Lake City, Utah, USA.
  • Gilissen C; Pediatric Neurology, University of Utah School of Medicine, Salt Lake City, Utah, USA.
  • Vissers LELM; Department of Pediatrics, Medical Center North, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Pfundt R; Department of Pediatrics, Medical Center North, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Kersseboom R; Department of Human Genetics, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Yttervik H; Department of Human Genetics, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Hansen GÅM; Department of Human Genetics, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands.
  • Falkenberg Smeland M; Center for genetic developmental disorders southwest, Zuidwester, Middelharnis, The Netherlands.
  • Butler KM; Department of Medical Genetics, University Hospital of North Norway, Tromsø, Norway.
  • Lyons MJ; Department of Medical Genetics, University Hospital of North Norway, Tromsø, Norway.
  • Carvalho CMB; Department of Pediatric Rehabilitation, University Hospital of North Norway, Tromsø, Norway.
  • Zhang C; Greenwood Genetic Center, Greenwood, South Carolina, USA.
  • Lupski JR; Greenwood Genetic Center, Greenwood, South Carolina, USA.
  • Potocki L; Pacific Northwest Research Institute (PNRI), Broadway, Seattle, Washington, USA.
  • Flores-Gallegos L; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
  • Morales-Toquero R; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
  • Petit F; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
  • Yalcin B; Human Genome Sequencing Center, Baylor College of Medicine, Houston, Texas, USA.
  • Tuttle A; Department of Pediatrics, Baylor College of Medicine, Houston, Texas, USA.
  • Elloumi HZ; Texas Children's Hospital, Houston, Texas, USA.
  • Mccormick L; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, USA.
  • Kukolich M; Texas Children's Hospital, Houston, Texas, USA.
  • Klaas O; Hospital Ángeles Puebla, Puebla, Mexico.
  • Horvath J; Hospital Ángeles Puebla, Puebla, Mexico.
  • Scala M; CHU Lille, Clinique de génétique, F-59000 Lille, France.
  • Iacomino M; Inserm UMR1231, University of Burgundy, 21000 Dijon, France.
  • Operto F; GeneDx, Gaithersburg, Maryland, USA.
  • Zara F; GeneDx, Gaithersburg, Maryland, USA.
  • Writzl K; Department of Genetics, Cook Children's Medical Center, Cook Children's Health Care System, Fort Worth, Texas, USA.
  • Maver A; Department of Genetics, Cook Children's Medical Center, Cook Children's Health Care System, Fort Worth, Texas, USA.
  • Haanpää MK; Institute for Human Genetics, University Hospital Muenster, Muenster, Germany.
  • Pohjola P; Institute for Human Genetics, University Hospital Muenster, Muenster, Germany.
  • Arikka H; Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, 16132, Genoa, Italy.
  • Iseli C; Medical Genetics Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
medRxiv ; 2024 Jan 17.
Article em En | MEDLINE | ID: mdl-38293053
ABSTRACT

Background:

We previously described the KINSSHIP syndrome, an autosomal dominant disorder associated with intellectual disability (ID), mesomelic dysplasia and horseshoe kidney,caused by de novo variants in the degron of AFF3. Mouse knock-ins and overexpression in zebrafish provided evidence for a dominant-negative (DN) mode-of-action, wherein an increased level of AFF3 resulted in pathological effects.

Methods:

Evolutionary constraints suggest that other mode-of-inheritance could be at play. We challenged this hypothesis by screening ID cohorts for individuals with predicted-to-be deleterious variants in AFF3. We used both animal and cellular models to assess the deleteriousness of the identified variants.

Results:

We identified an individual with a KINSSHIP-like phenotype carrying a de novo partial duplication of AFF3 further strengthening the hypothesis that an increased level of AFF3 is pathological. We also detected seventeen individuals displaying a milder syndrome with either heterozygous LoF or biallelic missense variants in AFF3. Consistent with semi-dominance, we discovered three patients with homozygous LoF and one compound heterozygote for a LoF and a missense variant, who presented more severe phenotypes than their heterozygous parents. Matching zebrafish knockdowns exhibit neurological defects that could be rescued by expressing human AFF3 mRNA, confirming their association with the ablation of aff3. Conversely, some of the human AFF3 mRNAs carrying missense variants identified in affected individuals did not complement. Overexpression of mutated AFF3 mRNAs in zebrafish embryos produced a significant increase of abnormal larvae compared to wild-type overexpression further demonstrating deleteriousness. To further assess the effect of AFF3 variation, we profiled the transcriptome of fibroblasts from affected individuals and engineered isogenic cells harboring +/+, DN/DN, LoF/+, LoF/LoF or DN/LoF AFF3 genotypes. The expression of more than a third of the AFF3 bound loci is modified in either the DN/DN or the LoF/LoF lines. While the same pathways are affected, only about one-third of the differentially expressed genes are common to these homozygote datasets, indicating that AFF3 LoF and DN variants largely modulate transcriptomes differently, e.g. the DNA repair pathway displayed opposite modulation.

Conclusions:

Our results and the high pleiotropy shown by variation at this locus suggest that minute changes in AFF3 function are deleterious.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2024 Tipo de documento: Article